Biden’s Drug Patent Proposal Sparks Fierce Debate on Innovation and Affordability

A Biden administration proposal that seeks to use governmental authority to sidestep patents for drugs developed with federal funding, with the aim of lowering drug prices, is facing robust opposition. This has been raised mostly by drugmakers, universities, and other concerned entities who argue that this action could stifle innovation. The plan’s approach hinges on…

Read More

Federal Circuit Revives Food Slicer Patent Dispute Between Weber Inc. and Provisur Technologies

In a significant development on Thursday, The Federal Circuit discarded two decisions by the Patent Trial and Appeal Board (PTAB). These decisions had previously found that Weber Inc. did not successfully demonstrate that claims in food slicer patents owned by its competitor, Provisur Technologies, were invalid. This decision by the Federal Circuit essentially revives the…

Read More

Bulleit Bourbon’s Battle for Bottle Design Distinctiveness Heads to Second Circuit

The distinctive contours of Bulleit bourbon brand’s whiskey bottles are slated to square off in the courtroom as the Second Circuit prepares to rule on a unique intellectual property case. The Southern District of New York previously rendered a decision stating this shape was sufficiently distinctive to merit protection under trademark laws. However, this judgment…

Read More

Thailand Considers Prosecuting Ex-Premier Shinawatra for Alleged Royal Insult

Thailand’s attorney general’s office has announced its consideration for prosecuting former Thai premier, Thaksin Shinawatra, over an alleged insult to the monarchy, an official announcement stated on Tuesday. The potential charges come at a time when Shinawatra is being considered for release under parole. The offense in question emanates from a 2015 interview Shinawatra gave…

Read More

Brooklyn Comedy Collective’s Trademark Lawsuit Persists Despite Competitor’s Name Change

In a recent court decision, a New York federal judge declined to conclude the trademark lawsuit lodged by Brooklyn Comedy Collective against its competitor, Old Man Hustle BKLYN Comedy Club. The lawsuit is based on a conflict over the latter’s name that Brooklyn Comedy Collective argues could potentially cause customer confusion, despite the club’s attempt…

Read More

Supreme Court Review Sought for Flawed ‘Obviousness’ Ruling in Drug Patent Invalidation

Two major pharmaceutical companies have requested that the U.S. Supreme Court examine an argument concerning ‘obviousness’ in drug patent invalidations. The companies insist that the Federal Circuit made an error in its ruling, which suggested that a reasonable expectation of success in a patent claim was a foregone conclusion, merely on the basis that a…

Read More